MS-102

N/A

Report date: 2024/04/12 17:51:35
NME

Base Information

Drug NameMS-102
Drug Alias NameMS102MS-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin-specific protease 2 inhibitors
TargetsUbiquitin-specific protease 2
Therapy Area/IndicationsCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarvard Medical School
China Registration ClassN/A

Develop Information

Active CompaniesHarvard Medical School
Inactive CompaniesN/A
Active IndicationsCoronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A